First Trust Nasdaq Pharmaceuticals ETF (FTXH): ETF
ETF traded on XNAS under symbol FTXH. Quoted in usd.
First Trust Nasdaq Pharmaceuticals ETF
+0.69%$43.43
XNAS:FTXHSector Equity
AUM $1.18B·YTD --·Yield --
XNAS:FTXH$43.43+0.69%AUM $1.18BAbout FTXH
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
Largest holdings
- LLY Eli Lilly and Company7.99%
- ABBV AbbVie Inc.7.76%
- JNJ Johnson & Johnson7.09%
- PFE Pfizer Inc.7.05%
- MRK Merck & Co., Inc.6.78%
- VTRS Viatris Inc.4.12%
- BIIB Biogen Inc.3.91%
- GILD Gilead Sciences, Inc.3.89%
- REGN Regeneron Pharmaceuticals, Inc.3.86%
- AMGN Amgen Inc.3.66%
Dividend History
Benchmark Comparison
Compared against
Performance Returns
Drawdown Chart
Analyst Coverage
Savings Plan Calculator
Total Invested
$70,000
Final Portfolio
$109,386
Total Return
+$39,386
(+56.3%)
Dividends Reinvested
$0
compounded into portfolio
Defaults are seeded from historical performance and trailing twelve-month yield. Past performance is not a forecast. Feel free to adjust any input to model your own assumptions.
ETF Key Metrics
AUM$1.18B
NAV$43.42
Premium/Discount+0.02%
Expense Ratio0.60%
Market Cap--
Shares Outstanding--
Inception DateSep. 20, 2016
Fund Details
IssuerFirst Trust
Asset ClassSector Equity
Beta--
SectorFinancial Services
DomicileUS
52-Week Range
$29.89$45.10
Current: $43.43
Volume
Volume111.94K
Avg Volume507.72K
Vol/Avg0.22x
30d
73.71K
60d
206.63K
90d
168.55K
Comparable ETFs